Meta-analysis & systematic review
Pooled RCTs — the most robust evidence we can find in biohacking topics. Examples: creatine monohydrate for strength output, NMN for plasma NAD+ levels.
Most biohacking protocols are built on studies with male subjects. Women need their own frame — cycle awareness, hormone sensitivity and a study selection that takes female physiology seriously. Here is the evidence-based overview.
Until the 1990s, women were excluded from most clinical studies — formally because of “cycle variability,” practically out of convenience. The FDA changed that in 1993, but the data deficit is still measurable: for many substances we know the effects on a 70 kg male body better than on a 60 kg female body with cyclical hormone fluctuations. Concrete consequences: creatine dosing is often based on male studies (3-5 g/day), while newer female studies suggest higher doses (5-10 g) for comparable cognitive effects. Intermittent fasting can disrupt the cycle when practiced too aggressively — less pronounced in men. Cold plunge lowers skin temperature more in women, which can shift recovery effects. Bottom line: a good biohacking approach for women does not copy male protocols, it accounts for cycle phase, hormone context and female-validated studies.
The female cycle (28 days typically, 21-35 days normal) significantly changes energy, sleep quality, stress tolerance, training performance and insulin sensitivity. Four phases are worth differentiating: **Menstruation (days 1-5):** lowest hormone levels, often lower training capacity — light cardio and mobility instead of PRs. Track iron loss (blood panel once a year recommended). **Follicular phase (days 6-14):** rising estrogen, best training window for strength and hypertrophy. Insulin sensitivity high — good phase for carb cycling or higher training volume. **Ovulation (day 14):** estrogen peak. Peak performance, but also increased injury risk (ACL risk in female athletes rises). Take warm-ups seriously. **Luteal phase (days 15-28):** progesterone-dominated. Higher calorie demand (+100-300 kcal/day), worse sleep, more cravings. Good phase for recovery, cardio instead of max strength, more sleep stack (magnesium, glycine).
Three blood markers are especially relevant for women and are checked too rarely: **Ferritin** should be above 50 ng/ml — many women with fatigue or hair loss sit below 30 without it showing up in standard GP screening (which only checks hemoglobin). Iron deficiency is the most common micronutrient gap in premenopausal women. **Thyroid (TSH, fT3, fT4, plus TPO antibodies if indicated)** is 5-8x more often disturbed in women than in men. Subclinical hypothyroidism (TSH 2.5-4.5) is often missed and explains energy and weight issues better than a vague “slow metabolism.” **Sex hormone panel (estradiol, progesterone cyclical, FSH, LH, plus DHEA-S, free testosterone if indicated)** should be measured as a baseline by age 35 at the latest — and regularly during perimenopause (from around 40). Measured early, comparable later.
Between 40 and 55, most women experience a dramatic hormonal shift: declining estradiol and progesterone, unstable cycles, hot flashes, sleep disturbances, bone density loss, mood and cognition changes. Evidence-based biohacking for this phase includes: **Intense strength training** (2-4x/week, focus on squat, deadlift, press) — protects bone density and muscle mass better than any pill. Studies (Watson et al., LIFTMOR trials) show measurable bone density gains in postmenopausal women. **Protein intake** of at least 1.6-2.0 g/kg bodyweight — anabolic resistance rises with age, more protein is needed for the same muscle protein synthesis. **Hormone replacement therapy (HRT)** re-evaluated based on evidence: the WHI study 2002 put HRT in disrepute, but reanalyses show a favorable risk/reward profile for women who start HRT within 10 years of menopause (KEEPS, ELITE). Medical supervision essential, but no longer a blanket prohibition.
Evidence, not hallucination
Evidence-based biohacking means every claim about sleep, supplements, longevity or performance stands or falls with the study it cites. Biohacking AI makes that study trail visible — with clickable PubMed links, transparent evidence tiers and honest labeling where research is still thin. Every biohacker should know whether they're following a meta-analysis or a mouse paper.
Pooled RCTs — the most robust evidence we can find in biohacking topics. Examples: creatine monohydrate for strength output, NMN for plasma NAD+ levels.
Gold standard for single studies. Causal claims are possible, but effect sizes vary widely. Examples: magnesium for cramps, ashwagandha for cortisol-driven stress.
Large population data, but no causality — useful hypothesis generators. Examples: vitamin D levels and mortality, sleep duration and dementia risk.
Plausibility yes, clinical proof no. We label this transparently so no one reads a mouse result as "proven." Examples: peptides like BPC-157, red-light therapy at the cell level.
Those four tiers underpin every answer on the platform — no study is cited without a tier label, and when the evidence is thin the AI says so openly.
The AI searches specifically for studies with female subjects — cycle, hormones, iron, thyroid, menopause — instead of copying male protocols 1:1.